(Q44482658)

3 December 2017

title

Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells (English)

1 reference

3 December 2017

6

1 reference

3 December 2017

0 references

V Albinet

1

1 reference

3 December 2017

M-L Bats

2

1 reference

3 December 2017

A Huwiler

3

1 reference

3 December 2017

P Rochaix

4

1 reference

3 December 2017

C Chevreau

5

1 reference

3 December 2017

T Levade

7

1 reference

3 December 2017

N Andrieu-Abadie

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

3 December 2017

1 reference

3 December 2017

volume

33

1 reference

3 December 2017

issue

26

1 reference

3 December 2017

page(s)

3364-3373

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.303

3 December 2017

exact match

0 references

cites work

Role of tissue stroma in cancer cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Melanoma-stroma interactions: structural and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Targeting the stromal fibroblasts: a novel approach to melanoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Fibroblasts contribute to melanoma tumor growth and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine-1-phosphate signaling and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Effects of lysophospholipids on tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

A brief history of melanoma: from mummies to mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Role of matrix metalloproteinases in melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

An oncogenic role of sphingosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Targeting sphingosine kinase-1 to inhibit melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

38 Isolation of fibroblasts from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingolipids in macroautophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

A rapid and sensitive method to measure secretion of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

Indium-111–Pentetreotide Scintigraphy and Somatostatin Receptor Subtype 2 Expression: New Prognostic Factors for Malignant Well-Differentiated Endocrine Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.303

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.303

1 reference

Dimensions Publication ID

3 December 2017

1015411542

0 references

1 reference